Managers / Q2 2023 · view latest →
GLOBEFLEX CAPITAL L P
CIK 0000921531 · 4365 EXECUTIVE DR #720, SAN DIEGO, CA, 92121 · 8586589060
Summary
Globeflex Capital L P reported $896M in U.S.-listed holdings across 466 positions for Q2 2023.
Its largest position, ARW, represents 4.0% of the portfolio.
Compared with Q1 2023, the fund opened 56 new positions and exited 60.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 81.6% · $731M
- Other · 11.2% · $100M
- ETP · 4.1% · $36M
- REIT · 1.6% · $14M
- ADR · 1.6% · $14M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GMGENERAL MOTORS CO | NEW | +238.3K | 238.3K | +$9M | $9M |
| CSRCENTERSPACE | NEW | +61.1K | 61.1K | +$4M | $4M |
| LMBLIMBACH HOLDINGS INC | NEW | +95.5K | 95.5K | +$2M | $2M |
| UTE0CANTALOUPE INC | NEW | +258.4K | 258.4K | +$2M | $2M |
| PEREGRINE PHARMACEUTICALS ORD | NEW | +134.2K | 134.2K | +$2M | $2M |
| CRD/ACRAWFORD & CO | NEW | +130.9K | 130.9K | +$1M | $1M |
| NRIXNURIX THERAPEUTICS INC | NEW | +143.2K | 143.2K | +$1M | $1M |
| FTDRFRONTDOOR INC | NEW | +41.4K | 41.4K | +$1M | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $661M | 387 | May 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $653M | 400 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $650M | 406 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.2B | 418 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.1B | 424 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.2B | 429 | Feb 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.0B | 464 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $957M | 466 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.0B | 478 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $980M | 471 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $854M | 463 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $896M | 466 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $819M | 470 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $790M | 476 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $582M | 491 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $410M | 479 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $493M | 469 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $488M | 456 | Feb 10, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2021 | $458M | 456 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $557M | 452 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $549M | 449 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $469M | 470 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $378M | 470 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $394M | 496 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $325M | 527 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $534M | 527 | Feb 7, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $458M | 515 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $480M | 514 | Aug 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $473M | 429 | May 10, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $420M | 430 | Feb 15, 2019 | RESTATEMENT | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.